Dr Tameryn Stringer
Tameryn has extensive experience in the design, synthesis and application of organometallics for an array of diseases, including cancer. Her main research interest focuses on the development of metal complexes for therapeutic purposes but is also interested in identifying the biological targets of small molecules and metallodrugs using a range of in vitro methodologies. As a new member of staff at UEA, she aims to advance her research towards the development of protein-targeting metallodrugs and chemical probes in order to understand mechanisms of action. Tameryn, alongside Dr Rianne Lord and her group, works towards the development of novel metal-based anticancer agents.